BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Archives
  • December 2025
  • November 2025
  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • September 2024
  • August 2024
  • July 2024
  • May 2024
  • April 2024
  • December 2023
  • October 2023
  • August 2023
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • December 2021
  • November 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Subscribe

BioTech Health X

622 posts

Biotech NewsCDT Equity (CDT) Surges After Company Boosts Bitcoin Holdings to 17.9 BTC — Is a Breakout Coming?

  • BioTech Health X
  • November 28, 2025
CDT Equity Inc. (NASDAQ:CDT), formerly known as Conduit Pharmaceuticals, is a uniquely structured, data-driven biopharmaceutical development company built…
0 Shares
0
0
0
0
0
0
0

Biotech NewsMicrobot Medical (MBOT) Surges 9.04% After FDA Breakthrough—LIBERTY™ System Set for 2026 Launch

  • BioTech Health X
  • November 28, 2025
Microbot Medical Inc. (NASDAQMBOT) is a pioneering medical technology company committed to transforming the future of minimally invasive…
0 Shares
0
0
0
0
0
0
0

Biotech NewsQuince (QNCX) Explodes 59% in 7 Days — Is Quince Therapeutics Headed for a Major Breakout?

  • BioTech Health X
  • November 28, 2025
Quince Therapeutics Inc. (NASDAQ:QNCX) is a clinical-stage biopharmaceutical company built on a foundation of scientific reinvention and strategic…
0 Shares
0
0
0
0
0
0
0

Biotech NewsMobile-health Network Solutions (MNDR) Skyrockets 33.69% After Announcing Massive Malaysia AI Data Center Expansion

  • BioTech Health X
  • November 28, 2025
Mobile-health Network Solutions (NASDAQ:MNDR) is an emerging player in the global digital health and AI-enabled healthcare ecosystem, established…
0 Shares
0
0
0
0
0
0
0

Biotech NewsCEL-SCI (CVM) Surges as Investors Revisit 10-Year Phase 3 Data and Multikine’s 14.1% OS Benefit

  • BioTech Health X
  • November 26, 2025
Cel-Sci Corporation (NYSE:CVM) is a long-established biotechnology company built on a singular mission: to transform the treatment of…
0 Shares
0
0
0
0
0
0
0

Biotech NewsTrevi Therapeutics (TRVI) Narrows Q3 Loss to $11.8M as Haduvio Advances Toward Major Milestone

  • BioTech Health X
  • November 26, 2025
Trevi Therapeutics, Inc. (NASDAQ:TRVI) is a clinical-stage biopharmaceutical company founded with a mission to develop transformative therapies for…
0 Shares
0
0
0
0
0
0
0

Biotech NewsSilexion Therapeutics (SLXN) Targets KRAS Mutation Market Worth $5.8B—Here’s Why Investors Are Watching Closely

  • BioTech Health X
  • November 26, 2025
Silexion Therapeutics Corp. (NASDAQ:SLXN) is a clinical-stage, oncology-focused biotechnology company built on a clear mission: to develop transformative,…
0 Shares
0
0
0
0
0
0
0

Biotech NewsQuantum BioPharma (QBIO) Emerges as Precision Medicine Breakthrough Leader

  • BioTech Health X
  • November 26, 2025
Quantum BioPharma (NASDAQ:QBIO) is an emerging biotechnology company built on a foundation of precision medicine, advanced molecular engineering,…
0 Shares
0
0
0
0
0
0
0

Biotech NewsNeOnc Technologies (NTHI) Stuns Wall Street With Breakthrough 21% Response Rate in Brain Cancer Trial

  • BioTech Health X
  • November 26, 2025
NeOnc Technologies Holdings Inc. (OTC:NTHI) is a multi–Phase 2 clinical-stage biopharmaceutical company founded to solve one of the…
0 Shares
0
0
0
0
0
0
0

Biotech NewsAnnovis Bio (ANVS) Director Buys 34,000 Shares—Is This the Biggest Insider Bullish Signal of 2025?

  • BioTech Health X
  • November 26, 2025
Annovis Bio, Inc. (NASDAQ:ANVS) is a clinical-stage biotechnology company founded with a singular mission: to develop transformative therapies…
0 Shares
0
0
0
0
0
0
0

Biotech NewsSurrozen (SRZN) Surges as Wnt Regeneration Pipeline Targets Wet AMD and DME

  • BioTech Health X
  • November 26, 2025
Surrozen Inc. (NASDAQ:SRZN) is a biotechnology company founded on the pioneering scientific vision that precise modulation of the…
0 Shares
0
0
0
0
0
0
0

Biotech NewsKazia Therapeutics (KZIA) Faces Nasdaq Hearing After Missing Compliance

  • BioTech Health X
  • November 26, 2025
Kazia Therapeutics Limited (NASDAQ:KZIA) is a clinical-stage oncology biotechnology company built on more than two decades of research…
0 Shares
0
0
0
0
0
0
0

Biotech NewsCalciMedica (CALC) Advances Phase 2 Trial for Acute Kidney Injury

  • BioTech Health X
  • November 25, 2025
CalciMedica Inc. (NASDAQ:CALC) is a clinical-stage biopharmaceutical company built on over a decade of pioneering research in calcium…
0 Shares
0
0
0
0
0
0
0

Biotech NewsCardio Diagnostics (CDIO) Surges as 15 New Provider Partnerships Accelerate National Adoption

  • BioTech Health X
  • November 25, 2025
Cardio Diagnostics (NASDAQ:CDIO) is a pioneering artificial intelligence-driven precision cardiovascular medicine company built on years of scientific discovery,…
0 Shares
0
0
0
0
0
0
0

Biotech NewsInspire Medical Systems (INSP) Soars 28% After CMS Approves Massive $10,000 Reimbursement Increase

  • BioTech Health X
  • November 25, 2025
Inspire Medical Systems (NYSE:INSP) is a pioneering medical technology company built on the mission of transforming the treatment…
0 Shares
0
0
0
0
0
0
0

Biotech NewsWize Pharma (WIZP) Gains Momentum as LO2A Shows Proven Success With 1.53M Packages Sold

  • BioTech Health X
  • November 25, 2025
Wize Pharma (OTC:WIZP) is a specialty pharmaceutical company focused on the development and commercialization of targeted ophthalmic treatments,…
0 Shares
0
0
0
0
0
0
0

Biotech NewsTurn Therapeutics (TTRX) Named Top Innovator in Atopic Dermatitis With GX-03 Breakthrough

  • BioTech Health X
  • November 23, 2025
Turn Therapeutics Inc. (NASDAQ:TTRX) is a clinical-stage biotechnology company built on a foundation of innovation in dermatology, advanced…
0 Shares
0
0
0
0
0
0
0

Biotech NewsHerbalife (HLF) Surges After Q3 2025 Beat

  • BioTech Health X
  • November 23, 2025
Herbalife Ltd. (NYSE:HLF) is a global health and wellness company with more than four decades of history built…
0 Shares
0
0
0
0
0
0
0
Recent Posts
  • Kymera Therapeutics (KYMR) Jumps 10.2% in a Month—Is Wall Street Pricing in a Major 2026 Breakout?
  • Biodexa Pharmaceuticals (BDRX) Launches Phase 3 Trial for eRapa — Can This $2.81M Biotech Transform FAP Treatment?
  • Galectin Therapeutics (GALT) Surges 10.5% After Insider Sells 120,000 Shares
  • Analysts Boost Target to $24 as Ocular Therapeutix (OCUL) Nears Major Catalyst
  • Enveric Biosciences (ENVB) Reports Breakthrough PTSD Results as EB-003 Moves Toward IND in 2026
Recent Comments
  • Novavax Announces Robust First Quarter 2024 Results and Strategic Partnerships • BioTech Health X on Novavax and Sanofi Forge $1.2 Billion Alliance to Boost COVID and Flu Vaccine Efforts
  • Thomas Shentz on Cellarity Expands Leadership Team to Continue Evolution of Breakthrough Platform to Encode Biology and Purposefully Create New Drugs
  • Tomasz Michałowski on Exclusive: Cel-Sci CEO Geert Kersten Talks Multikine, FDA Approval, CVM Future
  • Presenters Announced for 2021 William Blair Biotech Conference • BioTech Health X on William Blair Biotech Focus Conference 2021 Panel Schedule
Featured Posts
    • December 6, 2025
    Kymera Therapeutics (KYMR) Jumps 10.2% in a Month—Is Wall Street Pricing in a Major 2026 Breakout?
    • December 6, 2025
    Biodexa Pharmaceuticals (BDRX) Launches Phase 3 Trial for eRapa — Can This $2.81M Biotech Transform FAP Treatment?
    • December 6, 2025
    Galectin Therapeutics (GALT) Surges 10.5% After Insider Sells 120,000 Shares
    • December 6, 2025
    Analysts Boost Target to $24 as Ocular Therapeutix (OCUL) Nears Major Catalyst
    • December 5, 2025
    Enveric Biosciences (ENVB) Reports Breakthrough PTSD Results as EB-003 Moves Toward IND in 2026
Recent Posts
  • Sensei Biotherapeutics (SNSE) Cuts Workforce by 65% as It Prepares for a Potential Sale—Is a Major Buyout Coming?
    • December 5, 2025
  • Viking Therapeutics (VKTX) Surges After 78% of Patients Achieve Normal Glycemic Control in Obesity Trial
    • December 5, 2025
  • Biodexa Pharmaceuticals (BDRX) Launches Phase 3 Trial for eRapa — Can This $2.8M Biotech Deliver a Breakthrough?
    • December 5, 2025
Categories
  • BioTech CEO Interviews (9)
  • Biotech Info (5)
  • Biotech News (607)
  • Uncategorized (1)
BioTech Health X
Designed & Developed by BioTech Health X
  • About BioTech Health X
  • List of Modern Life Science Technologies
  • Biotechnology Company Directory – List of Major Biotech Companies
  • Contact Us
  • Privacy Policy

Subscribe to
Our Updates

Back to top